PT76919B - Process for preparing pharmaceutical mixture compositions with controlled release of active substance - Google Patents
Process for preparing pharmaceutical mixture compositions with controlled release of active substanceInfo
- Publication number
- PT76919B PT76919B PT76919A PT7691983A PT76919B PT 76919 B PT76919 B PT 76919B PT 76919 A PT76919 A PT 76919A PT 7691983 A PT7691983 A PT 7691983A PT 76919 B PT76919 B PT 76919B
- Authority
- PT
- Portugal
- Prior art keywords
- active substance
- controlled release
- preparing pharmaceutical
- mixture compositions
- pharmaceutical mixture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8203953A SE8203953D0 (sv) | 1982-06-24 | 1982-06-24 | Pharmaceutical mixture |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PT76919A PT76919A (en) | 1983-07-01 |
| PT76919B true PT76919B (en) | 1986-04-09 |
Family
ID=20347191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT76919A PT76919B (en) | 1982-06-24 | 1983-06-23 | Process for preparing pharmaceutical mixture compositions with controlled release of active substance |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0101418B1 (pt) |
| JP (1) | JPS5916822A (pt) |
| KR (1) | KR910000028B1 (pt) |
| AR (1) | AR231075A1 (pt) |
| AT (1) | ATE59286T1 (pt) |
| AU (1) | AU561954B2 (pt) |
| BG (1) | BG51341A3 (pt) |
| CA (1) | CA1214726A (pt) |
| CS (1) | CS257769B2 (pt) |
| CY (1) | CY1468A (pt) |
| DD (1) | DD209971A5 (pt) |
| DE (1) | DE3382086D1 (pt) |
| DK (1) | DK161365C (pt) |
| ES (1) | ES8403720A1 (pt) |
| FI (1) | FI85213C (pt) |
| GB (1) | GB2122490B (pt) |
| GR (1) | GR78604B (pt) |
| HK (1) | HK98786A (pt) |
| HU (1) | HU189300B (pt) |
| IE (1) | IE55204B1 (pt) |
| IS (1) | IS1325B6 (pt) |
| MY (1) | MY8700292A (pt) |
| NO (1) | NO168745C (pt) |
| NZ (1) | NZ204639A (pt) |
| PH (1) | PH21911A (pt) |
| PT (1) | PT76919B (pt) |
| SE (1) | SE8203953D0 (pt) |
| SU (1) | SU1722207A3 (pt) |
| ZA (1) | ZA833931B (pt) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0729927B2 (ja) * | 1983-04-09 | 1995-04-05 | 日研化学株式会社 | テオフィリン徐放性製剤 |
| SE8405611D0 (sv) * | 1984-11-09 | 1984-11-09 | Astra Laekemedel Ab | Process for stabilization of bacampicillin hydrochloride |
| IT1183575B (it) * | 1985-05-08 | 1987-10-22 | Eurand Spa | Formulazione deodorando ad effetto modulante sulla trfaspirazione |
| NL8503539A (nl) * | 1986-01-02 | 1987-07-16 | Warner Lambert Co | Sucrose-vrije preparaten. |
| US4780320A (en) * | 1986-04-29 | 1988-10-25 | Pharmetrix Corp. | Controlled release drug delivery system for the periodontal pocket |
| SE8605515D0 (sv) * | 1986-12-22 | 1986-12-22 | Astra Laekemedel Ab | A liquid dosage form for oral administration of a pharmaceutically active substance |
| US4874613A (en) * | 1987-03-06 | 1989-10-17 | Baker Cummins Pharmaceuticals, Inc. | Taste concealing pharmaceutical dosage unit |
| US5427935A (en) * | 1987-07-24 | 1995-06-27 | The Regents Of The University Of Michigan | Hybrid membrane bead and process for encapsulating materials in semi-permeable hybrid membranes |
| SE463542B (sv) * | 1987-08-31 | 1990-12-10 | Lejus Medical Ab | Granulaer instanticerbar produkt samt foerfarande foer dess framstaellning |
| WO1989010117A1 (en) * | 1988-04-19 | 1989-11-02 | Southwest Research Institute | Controlled release of active ingredients from capsules having a salt sensitive shell material |
| US5064650A (en) * | 1988-04-19 | 1991-11-12 | Southwest Research Institute | Controlled-release salt sensitive capsule for oral use and adhesive system |
| FR2653337B1 (fr) * | 1989-10-23 | 1992-02-07 | Dow Corning Sa | Element a liberation prolongee et procede pour le fabriquer. |
| CA2068402C (en) * | 1991-06-14 | 1998-09-22 | Michael R. Hoy | Taste mask coatings for preparation of chewable pharmaceutical tablets |
| US5364634A (en) * | 1991-11-08 | 1994-11-15 | Southwest Research Institute | Controlled-release PH sensitive capsule and adhesive system and method |
| DE4200821A1 (de) * | 1992-01-15 | 1993-07-22 | Bayer Ag | Geschmacksmaskierte pharmazeutische mittel |
| JP3265680B2 (ja) * | 1992-03-12 | 2002-03-11 | 大正製薬株式会社 | 経口製剤用組成物 |
| DE4312656C2 (de) * | 1993-04-19 | 1996-01-25 | Beiersdorf Ag | Kühlend wirkende kosmetische oder dermatologische Zusammensetzungen |
| DE4423078B4 (de) * | 1994-07-01 | 2005-01-13 | Awd.Pharma Gmbh & Co. Kg | Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung |
| CN1170596C (zh) * | 1995-05-02 | 2004-10-13 | 大正制药株式会社 | 口服用组合物 |
| DE19706978A1 (de) * | 1997-02-21 | 1998-08-27 | Ulrich Dr Posanski | Kombinationspräparat für oral applizierbare Antibiotika |
| US7943585B2 (en) | 2003-12-22 | 2011-05-17 | Sandoz, Inc. | Extended release antibiotic composition |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL297088A (pt) * | 1961-01-31 | |||
| US3689654A (en) * | 1970-09-14 | 1972-09-05 | Morton Norwich Products Inc | Pharmaceutical compositions |
| JPS50126822A (pt) * | 1974-02-22 | 1975-10-06 | ||
| SE8003805L (sv) * | 1980-05-21 | 1981-11-22 | Haessle Ab | En farmaceutisk beredning med forbettrade utlosningsegenskap |
| US4321253A (en) * | 1980-08-22 | 1982-03-23 | Beatty Morgan L | Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration |
| SE8103843L (sv) * | 1981-06-18 | 1982-12-19 | Astra Laekemedel Ab | Farmaceutisk mixtur |
| JPS57209223A (en) * | 1981-06-19 | 1982-12-22 | Tanabe Seiyaku Co Ltd | Microcapsule for intracranial anti hypotension and its production |
-
1982
- 1982-06-24 SE SE8203953A patent/SE8203953D0/xx unknown
-
1983
- 1983-05-30 ZA ZA833931A patent/ZA833931B/xx unknown
- 1983-05-30 CA CA000429157A patent/CA1214726A/en not_active Expired
- 1983-05-31 AT AT83850147T patent/ATE59286T1/de not_active IP Right Cessation
- 1983-05-31 DE DE8383850147T patent/DE3382086D1/de not_active Expired - Lifetime
- 1983-05-31 EP EP83850147A patent/EP0101418B1/en not_active Expired - Lifetime
- 1983-06-14 DK DK272383A patent/DK161365C/da not_active IP Right Cessation
- 1983-06-16 FI FI832197A patent/FI85213C/fi not_active IP Right Cessation
- 1983-06-20 BG BG61387A patent/BG51341A3/xx unknown
- 1983-06-20 AU AU15943/83A patent/AU561954B2/en not_active Expired
- 1983-06-20 NZ NZ204639A patent/NZ204639A/en unknown
- 1983-06-20 PH PH29088A patent/PH21911A/en unknown
- 1983-06-21 AR AR293393A patent/AR231075A1/es active
- 1983-06-22 IE IE1462/83A patent/IE55204B1/en not_active IP Right Cessation
- 1983-06-23 NO NO832293A patent/NO168745C/no not_active IP Right Cessation
- 1983-06-23 GR GR71768A patent/GR78604B/el unknown
- 1983-06-23 GB GB08317071A patent/GB2122490B/en not_active Expired
- 1983-06-23 HU HU832225A patent/HU189300B/hu not_active IP Right Cessation
- 1983-06-23 DD DD83252303A patent/DD209971A5/de unknown
- 1983-06-23 CS CS834636A patent/CS257769B2/cs unknown
- 1983-06-23 SU SU833607650A patent/SU1722207A3/ru active
- 1983-06-23 ES ES523536A patent/ES8403720A1/es not_active Expired
- 1983-06-23 PT PT76919A patent/PT76919B/pt unknown
- 1983-06-23 JP JP58111990A patent/JPS5916822A/ja active Granted
- 1983-06-24 IS IS2824A patent/IS1325B6/is unknown
- 1983-06-24 KR KR1019830002854A patent/KR910000028B1/ko not_active IP Right Cessation
-
1986
- 1986-12-18 HK HK987/86A patent/HK98786A/xx not_active IP Right Cessation
-
1987
- 1987-12-30 MY MY292/87A patent/MY8700292A/xx unknown
-
1989
- 1989-07-21 CY CY1468A patent/CY1468A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT76919B (en) | Process for preparing pharmaceutical mixture compositions with controlled release of active substance | |
| HUT35524A (en) | Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance | |
| IL68267A (en) | Derivatives of cycloalka(c),pyrrolcarboxylic acids,process for their preparation,and pharmaceutical compositions containing them | |
| IL59914A (en) | Esters of acyl-carnitines,process for their preparation and pharmaceutical compositions containing them | |
| PT83508A (en) | Process for the preparation of pharmaceutical compositions with controlled release | |
| PT77173B (en) | Process for preparing novel phenethanolamines and of pharmaceutical compositions containing the same | |
| DE3366393D1 (en) | Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same | |
| PT76523A (en) | Process for preparing phenoxyalkylcarboxylic acid derivatives and of pharmaceutical compositions containing the same | |
| PT77281A (en) | Process for preparing n-formyl and n-hydroxymethyl-3-phenoxy-1-azetidinecarboxamides and of pharmaceutical compositions containing the same | |
| PT76809A (en) | Process for preparing 1-sulfo-2-oxoazetidine derivatives and of pharmaceutical compositions containing the same | |
| PT76657B (en) | Process for preparing 4-aryl-4-piperidinecarbinols and of pharmaceutical compositions containing the same | |
| PT76688A (en) | Process for preparing novel aziridine and phenethanolamine derivatives and of pharmaceutical compositions containing the same | |
| PT77217A (en) | Process for preparing 3-phenoxy-1-azetidine-carboxamides and of pharmaceutical compositions containing the same | |
| PT77694B (en) | Process for the preparation of mevalono lactone analogs and their derivatives and pharmaceutical compositions containing them | |
| HUT37036A (en) | Process for preparing pharmaceutical compositions with retarded release of the active substance | |
| HUT34006A (en) | Process for preparing 5-acyl-2-/1h/-pyridinone derivatives and pharmaceutical compositions containing thereof as active substances | |
| HUT34018A (en) | Process for preparing 2-piperazinyl-quilazoline derivatives and pharmaceutical compositions containing compounds | |
| HUT38308A (en) | Process for preparing new prostaglandin derivatives and pharmaceutical compositions containing such compounds as active substances | |
| PT76734B (en) | Process for preparing therapeutically active dihydropyridines of intermediates for the process and of pharmaceutical compositions containing the same | |
| PT76426B (en) | Process for preparing novel 2-beta-d-ribofuranosylselenazole-4-carboxamide compounds and of pharmaceutical compositions containing the same | |
| HUT34123A (en) | Process for preparing pharmaceutical compositions containing derivatives of pyrazolone as active substances | |
| PT77282A (en) | Process for preparing substituted 1-pyridyloxy-3-indolylalkylamino-2-propanols and of pharmaceutical compositions containing the same | |
| DE3063160D1 (en) | Spiro compounds, process for their preparation and pharmaceutical compositions containing them | |
| DE3360421D1 (en) | Process for the preparation of carbonic-acid esters | |
| HUT34020A (en) | Process for preparing new cyano-guanidine derivatives and pharmaceutical compositions containing such derivatives as active substances |